Multiple sclerosis (MS) is more common in females than males and frequently affects women during their reproductive years. Thus, issues surrounding pregnancy and reproduction are of concern to women with MS. This review documents studies that shed light on reproductive issues in women with MS. The available literature was searched for papers relating to pregnancy and MS. Pregnancy is protective in MS in the short term, perhaps due to modulation of the immune system in pregnancy. It also possible that changes in the brain in pregnancy could protect against the effects of inflammation. The long-term effects of pregnancy also seem to be beneficial to MS, perhaps due to long-term epigenetic changes or possibly due to the effects of fetal microchimerism. Obstetric outcomes in women with MS are similar to those in the general population. In addition, there have been no reports of severe fetal abnormalities in babies exposed to first-line MS therapies. There is no good evidence that breast-feeding is protective in MS. There is no evidence that oral contraceptive pill use predisposes to MS, nor influences the clinical course of MS. After menopause, there is possible deterioration of MS, but it’s difficult to disentangle this from the effects of aging and the natural progressive history of MS. The strong biological effect of pregnancy on MS deserves further study, so that these mechanisms can possibly be replicated as therapies for MS.
DoriaAIaccarinoLArientiS. Th2 immune deviation induced by pregnancy: The two faces of autoimmune rheumatic diseases. Reprod Toxicol2006; 22: 234–241.
2.
SaitoSNakashimaAShimaT. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol2010; 63: 601–610.
3.
ZollerALSchnellFJKershGJ.Murine pregnancy leads to reduced proliferation of maternal thymocytes and decreased thymic emigration. Immunol2007; 121: 207–215.
4.
TibbettsTADeMayoFRichS. Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility. Proc Natl Acad Sci USA1999; 96: 12,021–12,026.
5.
SomersetDAZhengYKilbyMD. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunol2004; 112: 38–43.
6.
Sanchez-RamonSNavarroAJAristimunoC. Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity. Immunol Lett2005; 96: 195–201.
7.
PolanczykMJHopkeCHuanJ. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol2005; 170: 85–92.
8.
TaiPWangJJinH. Induction of regulatory T cells by physiological level estrogen. J Cell Physiol2008; 214: 456–464.
9.
LashleyLEVan der HoornMLVan der MastBJ. Changes in cytokine production and composition of peripheral blood leukocytes during pregnancy are not associated with a difference in the proliferative immune response to the fetus. Hum Immunol2011; 72: 805–811.
10.
DellaBSGiannelliSCozziV. Incomplete activation of peripheral blood dendritic cells during healthy human pregnancy. Clin Exp Immunol2011; 164: 180–192.
11.
BruntonPJRussellJA.Endocrine induced changes in brain function during pregnancy. Brain Res2010; 1364: 198–215.
12.
OatridgeAHoldcroftASaeedN. Change in brain size during and after pregnancy: Study in healthy women and women with preeclampsia. Am J Neuroradiol2002; 23: 19–26.
13.
ChristensenHLeachLSMackinnonA. Cognition in pregnancy and motherhood: prospectove cohort study. The British Journal of Psychiatry. 196:126–132.
14.
MacbethAHGautreauxCLuineVN. Pregnant rats show enhanced spatial memory, decreased anxiety, and altered levels of monoaminergic neurotransmitters. Brain Res2008; 1241: 136–147.
15.
LemaireVBillardJMDutarP. Motherhood-induced memory improvement persists across lifespan in rats but is abolished by a gestational stress. Eur J Neurosci2006; 23: 3368–3374.
16.
GreggCShikarVLarsenP. White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci2007; 27: 1812–1823.
17.
MoralesT. Recent findings on neuroprotection against excitotoxicity in the hippocampus of female rats. J Neuroendocrinol2011; 23: 994–1001.
18.
CabreraVCantuDRamosE. Lactation is a natural model of hippocampus neuroprotection against excitotoxicity. Neurosci Lett2009; 461: 136–139.
19.
GreggC. Pregnancy, prolactin and white matter regeneration. J Neurol Sci2009; 285: 22–27.
20.
NilssonSMakelaSTreuterE. Mechanisms of estrogen action. Physiol Rev2001; 81: 1535–1565.
21.
TillmanAJ. The effect of pregnancy on multiple sclerosis and its management. Res Publ Assoc Res Nerv Ment Dis1950; 28: 548–582.
22.
ConfavreuxCHutchinsonMHoursMM. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med1998; 339: 285–291.
23.
De Las HerasVDe AndresCTellezN. Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: A descriptive study in the Spanish population. Mult Scler2007; 13: 981–984.
24.
FernandezLNKlajnDAcionL. Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study). Mult Scler2009; 15: 555–562.
25.
FinkelsztejnAFragosoYDFerreiraML. The Brazilian database on pregnancy in multiple sclerosis. Clin Neurol Neurosurg2010; 113: 277–280.
26.
JalkanenAAlanenAAirasL. Pregnancy outcome in women with multiple sclerosis: Results from a prospective nationwide study in Finland. Mult Scler2010; 16: 950-955.
27.
RoulletEVerdier-TaileferMMAmarencoP. Pregnancy and multiple sclerosis: A longitudinal study of 125 remittent patients. J Neurol Neurosurg Psy1993; 56: 1062–1065.
28.
WorthingtonJJonesRCrawfordM. Pregnancy and multiple sclerosis: A 3-year prospective study. J Neurol1994; 241: 228–233.
29.
FinkelsztejnABrooksJPaschoalFJr. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG2011; 118: 790–797.
30.
VukusicSHutchinsonMHoursM. Pregnancy and multiple sclerosis (the PRIMS study): Clinical predictors of post-partum relapse. Brain2004; 127: 1353–1360.
31.
NeuteboomRFVerbraakEVoermanJS. First trimester interleukin 8 levels are associated with postpartum relapse in multiple sclerosis. Mult Scler2009; 15: 1356–1358.
32.
De SezeJChapelotteMDelalandeS. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler2004; 10: 596–597.
33.
AchironAKishnerIDolevM. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol2004; 251: 1133–1137.
34.
HaasJHommesOR. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis. Mult Scler2007; 13: 900–908.
35.
De GrootASMoiseLMcMurryJA. Activation of natural regulatory T cells by IgG Fc-derived peptide “Tregitopes.”Blood2008; 112: 3303–3311.
36.
VukusicSIonescuIEl-EtrM. The prevention of post-partum relapses with progestin and estradiol in multiple sclerosis (POPART’MUS) trial: Rationale, objectives and state of advancement. J Neurol Sci2009; 286: 114–118.
37.
McCombePAGreerJMMackayIR. Sexual dimorphism in autoimmune disease. Curr Mol Med2009; 9: 1058–1079.
38.
CornelioDBBragaRPRosaMW. Devic’s neuromyelitis optica and pregnancy: Distinction from multiple sclerosis is essential. Arch Gynecol Obstet2009; 280: 475–477.
39.
LaplaudDALerayEBarriereP. Increase in multiple sclerosis relapse rate following in vitro fertilization. Neurol2006; 66: 1280–1281.
40.
HellwigKBesteCBruneN. Increased MS relapse rate during assisted reproduction technique. J Neurol2008; 255: 592–593.
41.
HellwigKSchimrigkSBesteC. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur Neurol2009; 61: 65–68.
42.
ChenAGanorYRahimipourS. The neuropeptides GnRH-II and GnRH-I are produced by human T cells and trigger laminin receptor gene expression, adhesion, chemotaxis and homing to specific organs. Nat Med2002; 8: 1421–1426.
43.
Langer-GouldAHuangSMGuptaR. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol2009; 66: 958–963.
44.
AirasLJalkanenAAlanenA. Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis. Neurol2010; 75: 474–476.
45.
PortaccioEGhezziAHakikiB. Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurol2011; 77: 145–150.
46.
KiraJHaradaMYamaguchiY. Hyperprolactinemia in multiple sclerosis. J Neurol Sci1991; 102: 61–66.
47.
YamasakiKHoriuchiIMinoharaM. Hyperprolactinemia in optico-spinal multiple sclerosis. Intern Med2000; 39: 296–299.
NielsenNMJorgensenKTStenagerE. Reproductive history and risk of multiple sclerosis. Epidemiol2011; 22: 546–552.
50.
D’HoogheMBNagelsGUitdehaagBM. Long-term effects of childbirth in MS. J Neurol Neurosurg Psy2010; 81: 38–41.
51.
RunmarkerBAndersenO. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain1995; 118: 253–261.
52.
VerdruPTheysPD’HoogheMB. Pregnancy and multiple sclerosis: The influence on long term disability. Clin Neurol Neurosurg1994; 96: 38–41.
53.
KochMUyttenboogaartMHeersemaD. Parity and secondary progression in multiple sclerosis. J Neurol Neurosurg Psy2009; 80: 676–678.
54.
BassoOCampiRFrydenbergM. Multiple sclerosis in women having children by multiple partners. A population-based study in Denmark. Mult Scler2004; 10: 621–625.
55.
GilmoreWAriasMStroudN. Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients. J Neurol Sci2004; 224: 69–76.
56.
SarasteMVaisanenSAlanenA. Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancy. Gend Med2007; 4: 45–55.
57.
NeuteboomRFVerbraakEWierenga-WolfAF. Pregnancy-induced fluctuations in functional T-cell subsets in multiple sclerosis patients. Mult Scler2010; 16: 1073–1078.
58.
NeuteboomRFVerbraakEWierenga-WolfAF. The monocyte transcriptome during pregnancy in multiple sclerosis: Prominent expression of the Fc-receptor CD64. Mult Scler2011;17: 389–396.
59.
NeuteboomRFVerbraakEVoermanJS. Serum leptin levels during pregnancy in multiple sclerosis. Mult Scler2009; 15: 907–912.
60.
LopezCComabellaMTintoreM. Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients. Mult Scler2006; 12: 421–427.
61.
AirasLNikulaTHuangYH. Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G. J Neuroimmunol2007; 187: 205–211.
62.
GilliFLindbergRLValentinoP. Learning from nature: Pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. PLoS ONE2010; 5: e8962.
LonyaiAKodamaSBurgerD. Fetal Hox11 expression patterns predict defective target organs: A novel link between developmental biology and autoimmunity. Immunol Cell Biol2008; 86: 301–309.
65.
SimpkinsJWSinghM.More than a decade of estrogen neuroprotection. Alz Dement2008; 4: S131–S136.
66.
RoepkeTAQiuJSmithAW. Fasting and 17beta-estradiol differentially modulate the M-current in neuropeptide Y neurons. J Neurosci2011; 31: 11,825–11,835.
67.
SmithKJMcDonaldWI. The pathophysiology of multiple sclerosis: The mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci1999; 354: 1649–1673.
68.
SicotteNLLivaSMKlutchR. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol2002; 52: 421–428.
69.
GoldSMSasidharMVMoralesLB. Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha). Lab Invest2009; 89: 1076–1083.
70.
HolmqvistPWallbergMHammarM. Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas2006; 54: 149–153.
71.
BodhankarSWangCVandenbarkAA. Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells. Eur J Immunol2011; 41: 1165–1175.
72.
GarayLDeniselleMCLimaA. Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis. J Steroid Biochem Mol Biol2007; 107: 228–237.
73.
HarnessJCavanaghAMortonH. A protective effect of early pregnancy factor on experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J Neurol Sci2003; 216: 33–41.
74.
ZhangBHarnessJSomodevilla-TorresMJ. Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151. J Neurol Sci2000; 182: 5–15.
75.
ZhangBWalshNMNguyenKB. Early pregnancy factor treatment suppresses the inflammatory response and adhesion molecule expression in the spinal cord of SJL/J mice with experimental autoimmune encephalomyelitis and the delayed type hypersensitivity reaction ot trinitrochlorobenzene in normal BALB/c mice. J Neurol Sci2003; 212: 37–46.
76.
Athanasas-PlatsisSZhangBHillyardN. Early pregnancy factor suppresses the infiltration of lymphocytes and macrophages in the spinal cord of rats during experimental autoimmune encephalomyelitis but has no effect on apoptosis. J Neurol Sci2003; 214: 27–36.
77.
MortonH. Early pregnancy factor: An extracellular chaperonin 10 homologue. Immunol Cell Biol1998; 76: 483–496.
78.
McCombePA. Recombinant EPF/chaperonin 10 promotes the survival of O4-positive pro-oligodendrocytes prepared from neonatal rat brain. Cell Stress Chap2008; 13: 467–474.
79.
BroadleySVanagsDWilliamsB. Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis. Mult Scler2009; 15: 329–336.
80.
WillerCJHerreraBMMorrisonKM. Association between microchimerism and multiple sclerosis in Canadian twins. J Neuroimmunol2006; 179: 145–151.
81.
BlochEMReedWFLeeTH. Male microchimerism in peripheral blood leukocytes from women with multiple sclerosis. Chimerism2011; 2: 6–10.
82.
ZhuNEghbaliMHelgueraG. Alternative splicing of Slo channel gene programmed by estrogen, progesterone and pregnancy. FEBS Lett2005; 579: 4856–4860.
83.
MartinVRibierasSRioMC. The estrogen responsive element of the pS2 gene is recognized by a methylation sensitive DNA binding protein. Biol Chem1998; 379: 409–416.
84.
KellyVMNelsonLMChakravartyEF. Obstetric outcomes in women with multiple sclerosis and epilepsy. Neurol2009; 73: 1831–1836.
85.
Van der KopMLPearceMSDahlgrenL. Neonatal and delivery outcomes in women with multiple sclerosis. Ann Neurol2011; 70: 41–50.
86.
ChenYHLinHLLinHC. Does multiple sclerosis increase risk of adverse pregnancy outcomes? A population-based study. Mult Scler2009; 15: 606–612.
87.
DahlJMyhrKMDaltveitAK. Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. J Neurol2008; 255: 623–627.
88.
LuEDahlgrenLSadovnickA. Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs. Mult Scler2012; 18: 460–467.
89.
Sandberg-WollheimMAlteriEMoragaMS. Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy. Mult Scler2011; 17: 423–430.
90.
AmatoMPPortaccioEGhezziA. Pregnancy and fetal outcomes after interferon-beta exposure in multiple sclerosis. Neurol2010; 75: 1794–1802.
91.
Weber-SchoendorferCSchaeferC. Multiple sclerosis, immunomodulators, and pregnancy outcome: A prospective observational study. Mult Scler2009; 15: 1037–1042.
92.
SalminenHJLeggettHBoggildM. Glatiramer acetate exposure in pregnancy: Preliminary safety and birth outcomes. J Neurol2010; 257: 2020–2023.
93.
HoevenarenIADe VriesLCRijndersRJ. Delivery of healthy babies after natalizumab use for multiple sclerosis: A report of two cases. Acta Neurol Scand2011; 123: 430-433.
94.
HellwigKHaghikiaAGoldR. Pregnancy and natalizumab: Results of an observational study in 35 accidental pregnancies during natalizumab treatment. Mult Scler2011; 17: 958–963.
95.
HellwigKSchimrigkSChanA. A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis. J Neurol Sci2011; 307: 164–165.
96.
BaderAMHuntCODattaS. Anesthesia for the obstetric patient with multiple sclerosis. J Clin Anesth1988; 1: 21–24.
97.
ZorgdragerADe KeyserJ. Menstrually related worsening of symptoms in multiple sclerosis. J Neurol Sci1997; 149: 95–97.
98.
PozzilliCFalaschiPMaineroC. MRI in multiple sclerosis during the menstrual cycle: Relationship with sex hormone patterns. Neurol1999; 53: 622–624.
99.
HolmqvistPHammarMLandtblomAM. Symptoms of multiple sclerosis in women in relation to cyclical hormone changes. Eur J Contracept Reprod Health Care2009; 14: 365–370.
100.
AlonsoAClarkCJ.Oral contraceptives and the risk of multiple sclerosis: A review of the epidemiologic evidence. J Neurol Sci2009; 286: 73–75.
101.
HolmqvistPHammarMLandtblomAM. Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis. Fertil Steril2010; 94: 2835–2837.
102.
GreerJMMcCombePA. Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms. J Neuroimmunol2011; 234: 7–18.
103.
SlokaJSPryse-PhillipsWEStefanelliM. The relation between menarche and the age of first symptoms in a multiple sclerosis cohort. Mult Scler2006; 12: 333–339.
104.
RamagopalanSVValdarWCriscuoliM. Age of puberty and the risk of multiple sclerosis: A population based study. Eur J Neurol2009; 16: 342–347.
105.
KimHKuSYSungJJ. Association between hormone therapy and nerve conduction study parameters in postmenopausal women. Climacteric2011; 14: 488–491.
106.
FernandesdeAbreuDABabronMCRebeixI. Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis. Mult Scler2009; 15: 1146–1152.
107.
BayesHKWeirCJO’LearyC. Timing of birth and risk of multiple sclerosis in the Scottish population. Eur Neurol2010; 63: 36–40.
108.
SalzerJSvenningssonASundstromP. Season of birth and multiple sclerosis in Sweden. Acta Neurol Scand2010; 122: 70–73.
109.
StaplesJPonsonbyALLimL. Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: Longitudinal analysis. BMJ2010; 340: c1640.
110.
MontgomerySMBahmanyarSHillertJ. Maternal smoking during pregnancy and multiple sclerosis amongst offspring. Eur J Neurol2008; 15: 1395–1399.
111.
MirzaeiFMichelsKBMungerK. Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann Neurol2011; 70: 30–40.
112.
GardenerHMungerKLChitnisT. Prenatal and perinatal factors and risk of multiple sclerosis. Epidemiol2009; 20: 611–618.
113.
MungerKLChitnisTAscherioA. Body size and risk of MS in two cohorts of US women. Neurol2009; 73: 1543–1550.
114.
Weinstock-GuttmanBZivadinovRMahfoozN. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation2011; 8: 127.
